205 related articles for article (PubMed ID: 12404667)
21. Meta-analytical studies on new antidepressants.
Anderson IM
Br Med Bull; 2001; 57():161-78. PubMed ID: 11719915
[TBL] [Abstract][Full Text] [Related]
22. Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression.
Murphy GM; Hollander SB; Rodrigues HE; Kremer C; Schatzberg AF
Arch Gen Psychiatry; 2004 Nov; 61(11):1163-9. PubMed ID: 15520364
[TBL] [Abstract][Full Text] [Related]
23. Mirtazapine. A pharmacoeconomic review of its use in depression.
Holm KJ; Jarvis B; Foster RH
Pharmacoeconomics; 2000 May; 17(5):515-34. PubMed ID: 10977391
[TBL] [Abstract][Full Text] [Related]
24. Antidepressant treatment of the depressed patient with insomnia.
Thase ME
J Clin Psychiatry; 1999; 60 Suppl 17():28-31; discussion 46-8. PubMed ID: 10446739
[TBL] [Abstract][Full Text] [Related]
25. A risk-benefit assessment of mirtazapine in the treatment of depression.
Kasper S; Praschak-Rieder N; Tauscher J; Wolf R
Drug Saf; 1997 Oct; 17(4):251-64. PubMed ID: 9352961
[TBL] [Abstract][Full Text] [Related]
26. Tolerability and patient compliance.
Roose SP
J Clin Psychiatry; 1999; 60 Suppl 17():14-7; discussion 46-8. PubMed ID: 10446736
[TBL] [Abstract][Full Text] [Related]
27. Other Antidepressants.
Schwasinger-Schmidt TE; Macaluso M
Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
[TBL] [Abstract][Full Text] [Related]
28. Mirtazapine substitution in SSRI-induced sexual dysfunction.
Gelenberg AJ; McGahuey C; Laukes C; Okayli G; Moreno F; Zentner L; Delgado P
J Clin Psychiatry; 2000 May; 61(5):356-60. PubMed ID: 10847310
[TBL] [Abstract][Full Text] [Related]
29. Non response at week 4 as clinically useful indicator for antidepressant combination in major depressive disorder. A sequential RCT.
Kato M; Takekita Y; Koshikawa Y; Sakai S; Bandou H; Nishida K; Sunada N; Onohara A; Hatashita Y; Serretti A; Kinoshita T
J Psychiatr Res; 2017 Jun; 89():97-104. PubMed ID: 28213170
[TBL] [Abstract][Full Text] [Related]
30. The pharmacologic rationale for the clinical use of antidepressants.
Pinder RM
J Clin Psychiatry; 1997 Nov; 58(11):501-8. PubMed ID: 9413422
[No Abstract] [Full Text] [Related]
31. Pharmacology of rapid-onset antidepressant treatment strategies.
Blier P
J Clin Psychiatry; 2001; 62 Suppl 15():12-7. PubMed ID: 11444761
[TBL] [Abstract][Full Text] [Related]
32. Dual action antidepressants and some important considerations.
Gupta RK; Tiller JW; Burrows GD
Aust N Z J Psychiatry; 2003 Apr; 37(2):190-5. PubMed ID: 12656958
[TBL] [Abstract][Full Text] [Related]
33. [Antidepressants and their onset of action: a major clinical, methodological and pronostical issue].
Gourion D
Encephale; 2008 Jan; 34(1):73-81. PubMed ID: 18514154
[TBL] [Abstract][Full Text] [Related]
34. Partial response and nonresponse to antidepressant therapy: current approaches and treatment options.
Hirschfeld RM; Montgomery SA; Aguglia E; Amore M; Delgado PL; Gastpar M; Hawley C; Kasper S; Linden M; Massana J; Mendlewicz J; Möller HJ; Nemeroff CB; Saiz J; Such P; Torta R; Versiani M
J Clin Psychiatry; 2002 Sep; 63(9):826-37. PubMed ID: 12363125
[TBL] [Abstract][Full Text] [Related]
35. Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study.
Behnke K; Søgaard J; Martin S; Bäuml J; Ravindran AV; Agren H; Vester-Blokland ED
J Clin Psychopharmacol; 2003 Aug; 23(4):358-64. PubMed ID: 12920411
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.
Leinonen E; Skarstein J; Behnke K; Agren H; Helsdingen JT
Int Clin Psychopharmacol; 1999 Nov; 14(6):329-37. PubMed ID: 10565799
[TBL] [Abstract][Full Text] [Related]
37. Mirtazapine: a review of its use in major depression.
Holm KJ; Markham A
Drugs; 1999 Apr; 57(4):607-31. PubMed ID: 10235695
[TBL] [Abstract][Full Text] [Related]
38. Designing a new generation of antidepressant drugs.
Pinder RM
Acta Psychiatr Scand Suppl; 1997; 391():7-13. PubMed ID: 9265946
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of mirtazapine in major depressive disorder patients after SSRI treatment failure: an open-label trial.
Fava M; Dunner DL; Greist JH; Preskorn SH; Trivedi MH; Zajecka J; Cohen M
J Clin Psychiatry; 2001 Jun; 62(6):413-20. PubMed ID: 11465517
[TBL] [Abstract][Full Text] [Related]
40. The cost-effectiveness of mirtazapine versus paroxetine in treating people with depression in primary care.
Romeo R; Patel A; Knapp M; Thomas C
Int Clin Psychopharmacol; 2004 May; 19(3):125-34. PubMed ID: 15107654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
